MX2017011007A - Composicion para uso para mejorar la consistencia o la frecuencia de las heces en infantes o niños pequeños. - Google Patents

Composicion para uso para mejorar la consistencia o la frecuencia de las heces en infantes o niños pequeños.

Info

Publication number
MX2017011007A
MX2017011007A MX2017011007A MX2017011007A MX2017011007A MX 2017011007 A MX2017011007 A MX 2017011007A MX 2017011007 A MX2017011007 A MX 2017011007A MX 2017011007 A MX2017011007 A MX 2017011007A MX 2017011007 A MX2017011007 A MX 2017011007A
Authority
MX
Mexico
Prior art keywords
frequency
consistency
infants
composition
improve
Prior art date
Application number
MX2017011007A
Other languages
English (en)
Other versions
MX384122B (es
Inventor
Brassart Dominique
Sprenger Norbert
Egli Delphine
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52726945&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2017011007(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2017011007A publication Critical patent/MX2017011007A/es
Publication of MX384122B publication Critical patent/MX384122B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pediatric Medicine (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a una composición nutritiva que comprende al menos un oligosacárido fucosilado y al menos un oligosacárido N-acetilado, para usar en la prevención y/o el tratamiento del estreñimiento y/o en la mejora de la consistencia/frecuencia de las heces en un infante o un niño pequeño.
MX2017011007A 2015-03-05 2016-03-04 Composición para uso para mejorar la consistencia o la frecuencia de las heces en infantes o niños pequeños. MX384122B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15157724 2015-03-05
PCT/EP2016/054613 WO2016139329A1 (en) 2015-03-05 2016-03-04 Compositions for use in improving stool consistency or frequency in infants or young children

Publications (2)

Publication Number Publication Date
MX2017011007A true MX2017011007A (es) 2017-10-20
MX384122B MX384122B (es) 2025-03-14

Family

ID=52726945

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017011007A MX384122B (es) 2015-03-05 2016-03-04 Composición para uso para mejorar la consistencia o la frecuencia de las heces en infantes o niños pequeños.
MX2017010923A MX2017010923A (es) 2015-03-05 2016-03-04 Composiciones para usar en el mejoramiento de la consistencia o la frecuencia de las heces en infantes o niños pequeños.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2017010923A MX2017010923A (es) 2015-03-05 2016-03-04 Composiciones para usar en el mejoramiento de la consistencia o la frecuencia de las heces en infantes o niños pequeños.

Country Status (11)

Country Link
US (4) US10821124B2 (es)
EP (4) EP3264921B1 (es)
CN (3) CN122030617A (es)
AU (2) AU2016227596B2 (es)
ES (2) ES3004085T3 (es)
FI (1) FI3264922T3 (es)
MX (2) MX384122B (es)
PH (2) PH12017550039B1 (es)
PT (1) PT3264922T (es)
RU (2) RU2731154C2 (es)
WO (2) WO2016139330A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107105741A (zh) 2014-10-31 2017-08-29 雀巢产品技术援助有限公司 用于促进脑发育和认知的包含fut2‑依赖性低聚糖和乳糖‑n‑新四糖的组合物
RU2731154C2 (ru) * 2015-03-05 2020-08-31 Сосьете Де Продюи Нестле С.А. Композиция для применения в улучшении консистенции или частоты стула у младенцев или детей младшего возраста
RU2724590C2 (ru) * 2015-08-04 2020-06-25 Сосьете Де Продюи Нестле С.А. Питательные композиции с 2fl и lnnt для применения при индукции кишечной микробиоты, которая похожа на кишечную микробиоту младенцев на грудном вскармливании
PH12019550208B1 (en) 2017-05-24 2024-05-24 Socia‰Ta‰ Des Produits Nestla‰ S A Hmos blends for use in infants or young children for health purposes
CN111432661A (zh) 2017-12-22 2020-07-17 雀巢产品有限公司 用途是用于减少婴儿和幼儿的伤害感觉的组合物
CA3089049C (en) * 2018-03-08 2023-03-28 Purepharm Inc. Methods and compositions for preventing and treating conditions related to alpha-synuclein
CN110839702A (zh) * 2018-08-21 2020-02-28 内蒙古伊利实业集团股份有限公司 一种改善婴幼儿肠道菌群丰度和粪便气味的母乳低聚糖组合物及其应用
EP3897208B1 (en) * 2018-12-21 2025-02-26 Société des Produits Nestlé S.A. A nutritional composition comprising a combination of human milk oligosaccharides to improve the gastrointestinal barrier
US20220110985A1 (en) * 2019-06-04 2022-04-14 N.V. Nutricia Nutritional composition comprising 2'fucosyllactose and 3'galactosyllactose
MX2022006831A (es) 2019-12-06 2022-08-18 Nestle Sa Composiciones para usar en la reduccion de dolor y/o percepcion de dolor en infantes y niños pequeños.
AU2020399200A1 (en) * 2019-12-11 2022-06-09 Société des Produits Nestlé S.A. Compositions for use in the reduction of nociception and other health benefits in infants and young children
JP7790874B2 (ja) * 2021-03-31 2025-12-23 株式会社明治 乳幼児用排便促進剤
US11712445B2 (en) * 2021-04-30 2023-08-01 Sourabh Kharait Compositions and methods for improving gastrointestinal function in subjects with renal disease
CN120167627A (zh) * 2025-05-21 2025-06-20 美维仕(北京)健康管理有限公司 改善认知的包含益生菌与低聚糖的营养组合物及其用途

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016449A1 (en) 1990-04-16 1991-10-31 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5545553A (en) 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US20020019991A1 (en) 1998-04-30 2002-02-14 Abbott Laboratories Compositions containing an alpha 1,2-fucose linkage and uses thereof
DK1531832T3 (da) 2002-06-28 2009-07-27 Glykos Finland Oy Terapeutiske sammensætninger til anvendelse ved profylakse eller behandling af diarré
GB0308104D0 (en) 2003-04-08 2003-05-14 Novartis Nutrition Ag Organic compounds
EP2497478A3 (en) 2003-12-05 2012-11-07 Children's Hospital Medical Center Oligosaccaride compositions and use thereof in the treatment of infection
CN101420966B (zh) * 2006-03-10 2013-07-17 纽崔西亚公司 不可消化的糖用于在出生后给予婴儿最佳开始的用途
ES2668552T3 (es) 2007-03-21 2018-05-18 Nestec S.A. Sistema de seguridad para composiciones nutricionales en polvo
WO2008115046A1 (en) * 2007-03-22 2008-09-25 N.V. Nutricia Cereal-based infant nutrition with fibre
WO2008153377A1 (en) 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
AU2010277582A1 (en) * 2009-07-31 2012-02-02 Nestec S.A. Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
EP2563166B1 (en) 2010-04-27 2014-05-14 N.V. Nutricia Use of human milk oligosaccharides in infant nutrition
EP2454948A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2465509A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating acute respiratory tract infections
EP2455387A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2465507A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating skin diseases
CN107019701B (zh) 2010-12-31 2020-07-28 雅培制药有限公司 使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法
MY191538A (en) * 2010-12-31 2022-06-30 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
EP2792252B1 (en) * 2011-02-10 2018-09-12 Nestec S.A. Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
EP2707379A4 (en) * 2011-05-13 2014-10-08 Glycosyn LLC USE OF PURIFIED 2'-FUCOSYLLACTOSIS, 3-FUCOSYLLACTOSIS AND LACTODIFUCOTETRAOSE AS PREBIOTICS
EP2522232A1 (en) 2011-05-13 2012-11-14 Nestec S.A. Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof
CA2846603A1 (en) 2011-08-29 2013-03-07 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
WO2013161820A1 (ja) * 2012-04-23 2013-10-31 国立大学法人京都大学 ビフィズス菌の増殖促進用組成物
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
EP3082827A1 (en) * 2013-11-15 2016-10-26 Nestec S.A. Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by c-section
CN105722514A (zh) 2013-11-15 2016-06-29 雀巢产品技术援助有限公司 用于预防或治疗剖腹产婴儿或幼儿的坏死性小肠结肠炎的组合物
CN105722515A (zh) * 2013-11-15 2016-06-29 雀巢产品技术援助有限公司 用于预防或治疗有风险婴儿或幼儿的urt感染的组合物
WO2016046294A1 (en) * 2014-09-25 2016-03-31 Nestec S.A. INFANT FORMULA SYSTEM WITH ADAPTIVE LEVELS OF HUMAN MILK OLIGOSACCHARIDES (HMOs)
US10716816B2 (en) * 2014-10-24 2020-07-21 Evolve Biosystems Inc. Activated bifidobacteria and methods of use thereof
WO2016066175A1 (en) * 2014-10-29 2016-05-06 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
CN107105741A (zh) * 2014-10-31 2017-08-29 雀巢产品技术援助有限公司 用于促进脑发育和认知的包含fut2‑依赖性低聚糖和乳糖‑n‑新四糖的组合物
CN106998775A (zh) 2014-11-26 2017-08-01 雅培制药有限公司 具有RRR‑α‑生育酚、2’‑岩藻糖基乳糖和益生菌的婴儿配方
CN114532538A (zh) * 2015-03-05 2022-05-27 雀巢产品有限公司 用于预防或治疗婴儿或幼儿的耳炎或支气管炎的组合物
RU2731154C2 (ru) * 2015-03-05 2020-08-31 Сосьете Де Продюи Нестле С.А. Композиция для применения в улучшении консистенции или частоты стула у младенцев или детей младшего возраста
MX378680B (es) * 2015-03-05 2025-03-11 Soc Des Produits Nestle S A Star Composiciones para usar en la prevencion o el tratamiento de infecciones/inflamaciones gastrointestinales en infantes o niños pequeños.
RU2724590C2 (ru) * 2015-08-04 2020-06-25 Сосьете Де Продюи Нестле С.А. Питательные композиции с 2fl и lnnt для применения при индукции кишечной микробиоты, которая похожа на кишечную микробиоту младенцев на грудном вскармливании
CN119097632A (zh) * 2016-01-26 2024-12-10 雀巢产品有限公司 人乳低聚糖对抗日后的脂肪量过度积聚和相关的健康障碍
CN108495636A (zh) * 2016-01-26 2018-09-04 雀巢产品技术援助有限公司 通过预防过早肥胖反弹而对健康有益的人乳低聚糖
WO2017129639A1 (en) * 2016-01-26 2017-08-03 Nestec S.A. Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat a health disorder by increasing glp-1 secretion
AU2017213083A1 (en) * 2016-01-26 2018-05-10 Société des Produits Nestlé S.A. Compositions comprising sialylated oligosaccharides for use in infants or young children to prevent later in life obesity or related comorbidities and promote a healthy growth
PH12019550208B1 (en) * 2017-05-24 2024-05-24 Socia‰Ta‰ Des Produits Nestla‰ S A Hmos blends for use in infants or young children for health purposes
EP3897208B1 (en) * 2018-12-21 2025-02-26 Société des Produits Nestlé S.A. A nutritional composition comprising a combination of human milk oligosaccharides to improve the gastrointestinal barrier
AU2020399200A1 (en) * 2019-12-11 2022-06-09 Société des Produits Nestlé S.A. Compositions for use in the reduction of nociception and other health benefits in infants and young children

Also Published As

Publication number Publication date
WO2016139329A1 (en) 2016-09-09
PT3264922T (pt) 2025-01-07
MX384122B (es) 2025-03-14
US10821124B2 (en) 2020-11-03
ES3000670T3 (en) 2025-03-03
FI3264922T3 (fi) 2024-12-27
AU2016227596B2 (en) 2020-01-16
US20210023102A1 (en) 2021-01-28
PH12017550041A1 (en) 2018-01-15
ES3004085T3 (en) 2025-03-11
RU2017134672A3 (es) 2019-08-20
EP4508990A3 (en) 2025-04-23
EP3264921B1 (en) 2024-10-30
RU2017133801A3 (es) 2019-09-17
US20210177872A1 (en) 2021-06-17
CN107404931A (zh) 2017-11-28
MX2017010923A (es) 2018-01-16
PH12017550039B1 (en) 2022-07-20
RU2731154C2 (ru) 2020-08-31
EP3264922A1 (en) 2018-01-10
EP4494482A3 (en) 2025-04-23
EP3264921A1 (en) 2018-01-10
EP3264922B1 (en) 2024-10-30
AU2016227596A1 (en) 2017-07-27
WO2016139330A1 (en) 2016-09-09
RU2017133801A (ru) 2019-04-05
EP4494482A2 (en) 2025-01-22
PH12017550041B1 (en) 2022-08-05
RU2017134672A (ru) 2019-04-05
AU2016227597B2 (en) 2020-01-16
US20180078572A1 (en) 2018-03-22
AU2016227597A1 (en) 2017-07-27
CN122030617A (zh) 2026-05-15
PH12017550039A1 (en) 2018-01-15
CN107846957A (zh) 2018-03-27
US20180078573A1 (en) 2018-03-22
RU2731067C2 (ru) 2020-08-28
EP4508990A2 (en) 2025-02-19

Similar Documents

Publication Publication Date Title
MX384122B (es) Composición para uso para mejorar la consistencia o la frecuencia de las heces en infantes o niños pequeños.
PH12017550040A1 (en) Compositions for use in the prevention or treatment of gastrointestinal infections/inflammations in infants or young children
MX380540B (es) Composiciones para uso en la prevención o el tratamiento de otitis o bronquitis en infantes o niños pequeños.
MX382069B (es) Composiciones que comprenden 2fl y lnnt para controlar la ingesta de alimento y el crecimiento en infantes o niños pequeños.
PH12018501325A1 (en) Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat a health disorder by increasing glp-1 secretion
PH12016500773A1 (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by c-section
PH12018501262A1 (en) Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat allergies
PH12018501328A1 (en) Compositions comprising 2fl and lnnt for use in infants or young children to prevent later in life obesity or related comorbidities
MX377225B (es) Mezcla sintetica de oligosacaridos de la leche humana (hmo) y composición que la contiene.
MX382478B (es) Bifidobacterias activadas y metodos de uso de las mismas.
MX2016006060A (es) Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños.
PH12020550465A1 (en) Compositions comprising at least one n-acetylated and at least one fucosylated oligosaccharide for use in the promotion of digestive capacity in infants and young children
PH12015502543B1 (en) Anti-regurgitation composition maintaining gut motility
PH12021551074A1 (en) A nutritional composition comprising 2`-fucosyllactose (2` fl) to improve the gastrointestinal barrier
PH12019500092A1 (en) Nutritional compositions for infants and/or young children comprising oligosaccharides
BR112017007362A2 (pt) composições nutricionais compreendendo sn-1(3)-monoacilgliceróis para uso no tratamento de atrasos de crescimento em bebês ou crianças
NZ753208A (en) Anti-regurgitation composition maintaining gut motility
TH2001005750A (th) องค์ประกอบทางโภชนาการสำหรับใช้ในการป้องกันผิวแห้ง